Previous findings have suggested that blocking TAMs and PD-L1 in CCA can reduce CCA progression, but G-MDSCs disable TAM and PD-L1 blockade by impairing T-cell-mediated immune escape responses. This evidence concerns the gene CD274 and cholangiocarcinoma.